Member Info for belgrano

Bidding above the ask now on OPTI, perhaps a T20.

Hi Munchbox,
SBTX up 10% today, products have already been tested non officially prior to trial. Opti and SBTX have a 100% track record of successful trials, they dont like wasting any money.
In my book both companies a screaming buy, as big Pharma about to get really intrested.
With the recent company appointment, and his big phama links to takeover, I do wonder if SOH is going for a nasdaq launch followed by a bidding war. We know he sold his previous company if a little too soon, is the time now right??

Hi Munchbox, nearly every trial opti and its subsideries have performed has been a success to date. they have tested the products in a non official capacity first to check efficiency. dont want to waste money. This would be a big pharma breakthrough, and transformational for sbtx and opti.

another highly skilled appointment, may partly reveal the stock intrest in opti, strong pharma links and institutional investment links..excellent.

Nice top up buy at the end there by someone with 50k spare at full ask. Wasnt much stock about at all with many investors expecting a large re-rate, bet that will further increase pressure on the MM's to raise prices further to attract sellers.
A good start, and a very strong buy.

they were not using opti's, there is only one sweet fibre discovered. .opti hold all the patents. Belive the best is yet to come with Opti.

think its 22.5% bob, after the recent sbtx fund raise. hence 7m, but mmany posters saying success in medical trials could make this another 100 plus bagger. however they are miossing something.
The croda deal will make them easily self sufficient in time without the trial being a success...that s just the cake icing.
Smart money will opt for opti, Tom's lemmings will rush for SBTX..
Actually both is good in my books, as ive got 7 figs, built up over many years.

think the sbtx trials get overlooked by opti holders, if successful sbtx holdings could be worth 20M, its currently worth 7M.
Opti is hugely undervalued, a fact that will not be missed by the probotic and prebotic aware and savvy NASDAQ investor.
get in now (if you can), most like me have already filled me boots in both.

Medical grade treatment would be sought after world wide. Don't think for a minute that some unofficial tests havnt been carried out and with very positive results. Our top research scientist Cath, went back into her best role which is head of labs when these opportunities were first recognised.
the best is yet to come.

if the sbtx trials work, that could be a 10 bagger alone.

SBTX up 18% today, thats 33% in two days alone...lot of value to opti.

looks like they are after our stock...make em pay a load more, hold tight.

yes some really queer trades, who buys 5 shares.

Another great start with SBTX, up over 8% already. Seems its being tipped for stardom. Opti have just under 30% of the company, so it adds value here, which does not get recognised.

its not a case of ryanair not wanting uk investors money, its eu law preventing non eu owned members flying across its regions and airspace.
not a level playing field by any means. however they are a great hold investment.

see us uk investors wont be able to buy stock from Friday. Treated as second class citizens, but our money has and is good at keeping this company 's buoyant share price up.

Hi Stoater,
You pose a very good and fair question, however dont think your comments about jam tomorrow is justified or true however, being still undewater myself I fully understand your justified frustration. However for my 6 eggs and possibly wrong I'll have a stab at answering your question, and also why I'm still bullish despite poor price performance.

As we both know, price is driven by buys verses sells, we have seen more sells over the last few years than buys and its depressed the price to where we are now.
There are quite a few major holders in this company like yorkshire seed fund for example, who provide "seed corn" funding for companies like opti with great prospects, in researching products and turning them into commercial companies. They like others bought large percentages at 6p. They hold for a few years then withdraw their funds in orderly fashion to invest in the next start up company.
I believe what we have been seeing with the chunky block sells over many months is that operation which is balanced against the "topping up buys" with investors like you and me . This has stopped the price rise, which in normal market conditions it would have done.
What will change this transition..wella couple of things..
Good company audited performance...should be end of this year.
Other large players buying stock...the europe run around to get other investors..didn't work that well, however nasdaq transition probably will.
Or the obvious..the sellers run out of of stock to sell.

Good RNS on SBTX givinfg important end of year reports. Products all on track and plenty of cash in the bank.
Has a knock on effect on OPTI due to the 30% share ownership.
Initial market reaction is positive.

yes, remember most payments are leveraged towards the end of the second half. This is by an order of magnitude not just a modest increase on the 1st half.
1st half 2020 was 400% increase on 1st half 2019, I'm looking to see the momenteum continuing, this half and through 2021.
With many internatioal deals now starting to give regular royalties we'll see that income stream ramping up, should be well placed this year to capture the new year diet rush, especially after lockdown has made a lot of us a little portly.

We are hearing through the grapevine that all sections hope to be in profit by year end, indeed sales are very good and increasing.
When we actually see the audited results giving confirmation of "in the black", there will be a rush to buy, but I believe stock may get a little short, and certainly not at todays prices.
Beauty of these boards is for those with "the vision" to see whats coming as the company becomes established worldwide.
Easy to take uk as a snapshot, but it does not reveal the right picture.